• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期慢性肾脏病患者的饮食磷限制:益处、挑战及新出现的策略

Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.

作者信息

Gutiérrez Orlando M, Wolf Myles

机构信息

Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

出版信息

Semin Dial. 2010 Jul-Aug;23(4):401-6. doi: 10.1111/j.1525-139X.2010.00750.x. Epub 2010 Jun 14.

DOI:10.1111/j.1525-139X.2010.00750.x
PMID:20557490
Abstract

Hyperphosphatemia is an independent risk factor for mortality in patients on maintenance dialysis. Since phosphorus clearance by standard three times-weekly dialysis is insufficient to balance ongoing dietary phosphorus intake, strategies to prevent absorption of dietary phosphorus are essential for attenuating increased serum levels. Dietary phosphorus binders are used widely for this purpose but dietary phosphorus restriction is relatively underutilized, most likely because of the logistical complexity of instituting and monitoring a low phosphorus diet, and for fear of worsening protein-energy wasting, which itself is a potent risk factor for mortality. In this review, we propose sustainable strategies for reducing phosphorus intake while avoiding exacerbation of protein-energy wasting. The approach is based on recognition of the dissociation between protein and phosphorus content in phosphorus-rich processed foods and the varying phosphorus bioavailability in different dietary sources. Controlling serum phosphate levels is among the most challenging aspects of day-to-day dialysis care but integration of sensible dietary interventions will likely improve phosphorus control.

摘要

高磷血症是维持性透析患者死亡的独立危险因素。由于标准的每周三次透析对磷的清除不足以平衡持续的饮食磷摄入,因此预防饮食磷吸收的策略对于减轻血清水平升高至关重要。饮食磷结合剂广泛用于此目的,但饮食磷限制的使用相对不足,最可能的原因是制定和监测低磷饮食在后勤方面较为复杂,并且担心会加重蛋白质能量消耗,而蛋白质能量消耗本身就是死亡的一个重要危险因素。在本综述中,我们提出了可持续的策略来减少磷摄入,同时避免加重蛋白质能量消耗。该方法基于认识到富含磷的加工食品中蛋白质和磷含量之间的分离以及不同饮食来源中磷的生物利用度不同。控制血清磷酸盐水平是日常透析护理中最具挑战性的方面之一,但合理的饮食干预措施的整合可能会改善磷的控制。

相似文献

1
Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.晚期慢性肾脏病患者的饮食磷限制:益处、挑战及新出现的策略
Semin Dial. 2010 Jul-Aug;23(4):401-6. doi: 10.1111/j.1525-139X.2010.00750.x. Epub 2010 Jun 14.
2
Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.腹膜透析患者中高磷血症患病率低,与残余肾功能无关。
J Ren Nutr. 2007 Nov;17(6):389-96. doi: 10.1053/j.jrn.2007.08.010.
3
Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake.正常健康状态及慢性肾脏病患者的磷稳态,特别强调膳食磷摄入量。
Semin Dial. 2007 Jul-Aug;20(4):295-301. doi: 10.1111/j.1525-139X.2007.00309.x.
4
Salivary glands: a new player in phosphorus metabolism.唾液腺:磷代谢的新角色。
J Ren Nutr. 2011 Jan;21(1):39-42. doi: 10.1053/j.jrn.2010.11.007.
5
Management of hyperphosphatemia.高磷血症的管理
Hemodial Int. 2006 Oct;10(4):338-45. doi: 10.1111/j.1542-4758.2006.00126.x.
6
[Information about phosphorus additives and nutritional counseling].[关于磷添加剂和营养咨询的信息]
Clin Calcium. 2012 Oct;22(10):1583-91.
7
Practical approaches to management of hyperphosphatemia: can we improve the current situation?
Blood Purif. 2007;25(1):120-4. doi: 10.1159/000096410. Epub 2006 Dec 14.
8
Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.非透析慢性肾脏病患者早期开始低磷饮食治疗的批判性综述
J Ren Care. 2009 Mar;35 Suppl 1:71-8. doi: 10.1111/j.1755-6686.2009.00064.x.
9
Phosphate restriction in diet therapy.饮食疗法中的磷酸盐限制
Contrib Nephrol. 2007;155:113-124. doi: 10.1159/000101004.
10
Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia.透析患者的饮食磷酸盐限制:高磷血症治疗的新方法。
Nutr Metab Cardiovasc Dis. 2011 Nov;21(11):879-84. doi: 10.1016/j.numecd.2010.02.021. Epub 2010 Jul 6.

引用本文的文献

1
Breast Cancer and Bone Mineral Density in a U.S. Cohort of Middle-Aged Women: Associations with Phosphate Toxicity.美国中年女性队列中的乳腺癌与骨矿物质密度:与磷酸盐毒性的关联
Cancers (Basel). 2023 Oct 21;15(20):5093. doi: 10.3390/cancers15205093.
2
The efficacy and safety of cuttlebone for lowering serum phosphate in patients with end-stage renal disease: a meta-analysis of randomized controlled trials.乌贼骨降低终末期肾病患者血清磷水平的疗效及安全性:一项随机对照试验的荟萃分析
Front Pharmacol. 2023 Jul 24;14:1206366. doi: 10.3389/fphar.2023.1206366. eCollection 2023.
3
Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.
高磷血症会增加炎症反应,从而加重贫血和骨骼肌消耗,而与 FGF23-FGFR4 信号无关。
Elife. 2022 Mar 18;11:e74782. doi: 10.7554/eLife.74782.
4
Pilot Randomized Controlled Trial of a Standard Versus a Modified Low-Phosphorus Diet in Hemodialysis Patients.血液透析患者标准低磷饮食与改良低磷饮食的前瞻性随机对照试验
Kidney Int Rep. 2020 Aug 18;5(11):1945-1955. doi: 10.1016/j.ekir.2020.08.008. eCollection 2020 Nov.
5
Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study.在接受血液透析的患者中,使用磷酸盐结合剂与感染相关和全因死亡率的关系:Q 队列研究。
Sci Rep. 2018 Jul 30;8(1):11387. doi: 10.1038/s41598-018-29757-0.
6
The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease.学者们的羡慕:将弗雷明汉心脏研究的经验教训应用于慢性肾脏病的预防
Rambam Maimonides Med J. 2015 Jul 30;6(3):e0029. doi: 10.5041/RMMJ.10214.
7
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.慢性肾脏病中降低磷酸盐和成纤维细胞生长因子23的原理及方法
J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12.
8
A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease.一种以磷酸盐为核心的慢性肾脏病病理生理学与治疗范式。
Kidney Int Suppl (2011). 2013 Dec;3(5):420-426. doi: 10.1038/kisup.2013.88.
9
Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.口服柠檬酸铁对血液透析患者血清磷的影响:多中心、随机、双盲、安慰剂对照研究。
J Nephrol. 2015 Feb;28(1):105-13. doi: 10.1007/s40620-014-0108-6. Epub 2014 May 20.
10
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence.终末期肾病患者的高磷血症:评估当前证据将治疗依从性与结局联系起来。
BMC Nephrol. 2013 Jul 18;14:153. doi: 10.1186/1471-2369-14-153.